BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kusowska A, Kubacz M, Krawczyk M, Slusarczyk A, Winiarska M, Bobrowicz M. Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma. Int J Mol Sci 2022;23:1501. [PMID: 35163421 DOI: 10.3390/ijms23031501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mata-molanes JJ, Rebollo-liceaga J, Martínez-navarro EM, Manzano RG, Brugarolas A, Juan M, Sureda M. Relevance of Fc Gamma Receptor Polymorphisms in Cancer Therapy With Monoclonal Antibodies. Front Oncol 2022;12:926289. [DOI: 10.3389/fonc.2022.926289] [Reference Citation Analysis]
2 Li Y, Zhou H, Zou L, Scicchitano P. Influence of Statins on the Survival Outcomes of Patients with Diffuse Large B Cell Lymphoma: A Systematic Review and Meta-Analysis. International Journal of Clinical Practice 2022;2022:1-9. [DOI: 10.1155/2022/5618290] [Reference Citation Analysis]